| Pharma Business | Manufacturing and trading of pharmaceutical bulk drugs and intermediates. | Experienced management and established partnerships in pharma supply chain. | B2B pharma companies and research institutions. | Active pharmaceutical ingredients and specialty intermediates. | 7 | 27 | Sales of bulk drugs and intermediates to pharmaceutical companies. | Direct sales with negotiated contracts. | Increasing demand for quality bulk drugs and intermediates, and new product launches. | |
| Financial Activity | Legacy financial services activities related to investments. | | Investors and internal group companies. | | 0 | 1 | Returns and interest from past investments. | Investment income based. | Limited as company shifts focus away from finance. | |
| Investment Activity | Portfolio management and trading of securities. | | General market investments. | | 0 | 1 | Capital gains and dividends. | Transactional investment returns. | Minimal focus in current business model. | |
| Foods | Operations through subsidiary in food industry. | | Retail customers in food sector. | | 0 | 0 | Sales of food products. | Direct sales. | Initial phase with limited operations. | |
| Trading in Shares | Trading activities in stock markets. | | Market traders. | | 1 | 4 | Trading gains and brokerage. | Transactional. | Volatile and not core focus. | |
